Not checkedNot checked for notices yet.
Cardiac glycosides and COVID-19: would it be a promising therapeutic approach?
EFTYCHIOS SINIORAKIS, SPYRIDON ARVANITAKIS, MAXIMILIANOS ELKOURIS
Anais da Academia Brasileira de Ciências · 2020
doi:10.1590/0001-3765202020201080 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Cardiac glycosides have been found to have an anti-viral effect. This was noted in the past during various epidemics including MERS and SARS. It is due to their inhibitory effect on the Na, K-ATPase membrane pump. Furthermore, they exhibit anti-inflammatory properties. These preclinical observations may prove useful in further clinical utility of these well-known compounds in the current COVID-19 pandemic.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.